Last updated 16 July 2021
The last batch of global asparaginase Erwinia chrysanthemi/crisantaspase (Erwinia L-asparaginase) distribution by Jazz has been released, and this was the last batch made available by Porton Biopharma Limited (PBL) to Jazz. Jazz’s right to distribute the product ceased after this batch. All supply beyond this batch is the responsibility of PBL and Clinigen.
Any questions related to future batch availability should be directed to PBL’s new partner, Clinigen.
Jazz thanks the healthcare providers, health authorities and patient community for their engagement and partnership over the last several years and the company remains committed to this patient population.
This page is intended for U.S. residents only. We are not accepting requests from individuals in states other than California, Washington and Nevada. If you are not a resident of any of these states, please do NOT continue.
Please select and enter the required fields on the form below. We need this information to process your request and to take necessary steps to verify your identity. We will contact you if we need any additional information.
Please note that your rights may vary under applicable state privacy laws and may be subject to limitations.
